SCHEMBL4628871

SCHEMBL4628871

CC1(C)CCC2=C(S1)C(=O)c1ccccc1C2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.50
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPT P10636 5/20 0.45
KDM4E B2RXH2 4/20 0.45
BLM P54132 4/20 0.45
LMNA P02545 4/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 4/20 0.45
CES1 P23141 3/20 0.45
THRB P10828 3/20 0.45
RECQL P46063 3/20 0.45
MAPK1 P28482 3/20 0.45
TP53 P04637 3/20 0.45
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C9 P11712 3/20 0.45
ALOX15 P16050 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL416283 0.89 MALT1 (0.51) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL4657699 0.69 S100A4 (0.67) IDO1MEN1KMT2AMAPTKDM4E
Alpha-Lapachone SCHEMBL102553 0.67 IDO1 (1.00) IDO1MEN1KMT2AMAPTKDM4E
Alpha-Lapachone SCHEMBL29355317 0.67 IDO1 (1.00) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL12798036 0.64 CES1 (0.54) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL545308 0.63 MEN1 (0.55) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL29519720 0.63 MEN1 (0.55) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL28215631 0.63 MEN1 (0.55) IDO1MEN1KMT2AMAPTKDM4E
Lapachone SCHEMBL107042 0.62 MALT1 (1.00) IDO1MEN1KMT2AMAPTKDM4E
SCHEMBL11580301 0.62 CDC25B (0.61) IDO1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567515-A4 NOVEL LAPACHONE COMPOUNDS AND METHODS OF USE THEREOF ARQULE INC (US) 2008-04-23 EP disclosed
EP-1567515-A2 NOVEL LAPACHONE COMPOUNDS AND METHODS OF USE THEREOF ARQULE, INC. (US) 2005-08-31 EP disclosed
US-20040266857-A1 Novel lapachone compounds and methods of use thereof HINES GLOBAL EDUCATION 2004-12-30 US disclosed
WO-2004045557-A2 NOVEL LAPACHONE COMPOUNDS AND METHODS OF USE THEREOF ARQULE, INC. (US) 2004-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266857-A1 Novel lapachone compounds and methods of use thereof XIAP, MKI67, PIN1 IDO1 1021/4885MEN1 2813/4885KMT2A 3488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.